• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Efavirenz, Emtricitabine and Tenofovir (Simplir®) in HIV infection – comparison with other brands in Argentina]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (squamous cell carcinoma of the head and neck) - Addendum to Commission A17-24]
2017     NIHR Health Services and Delivery Research programme Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial: a three-armed randomised controlled trial of financial incentives
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Alprostadil for nonrevascularizable critical lower limb ischemia]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (squamous cell carcinoma of the head and neck) - Addendum to A-17-24]
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Interventions to improve foster children's mental and physical health]
2017     NIHR Public Health Research (PHR) programme Increasing boys' and girls' intention to avoid teenage pregnancy: a cluster randomised control feasibility trial of an interactive video drama based intervention in post-primary schools in Northern Ireland
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Atazanavir/cobicistat (Evotaz®) in HIV infection]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Etelcalcetide (secondary hyperparathyroidism) - Addendum]
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Methods to increase chronically ill patients' participation in health care and services]
2017     NIHR Health Technology Assessment programme Cognitive behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Functioning and disability - an evidence map]
2017     European Network for Health Technology Assessment (EUnetHTA) Repetitive transcranial magnetic stimulation for treatment-resistant major depression
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Deferred parathyroid autograft with cryopreserved tissue for the surgical management of hyperparathyroidism]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Decision aid for biomarker tests in breast cancer - Addendum to Commission D14-01]
2017     NIHR Health Technology Assessment programme A novel peer-support intervention using motivational interviewing for breastfeeding maintenance:a UK feasibility study
2017     NIHR Health Technology Assessment programme Prehospital randomised assessment of a mechanical compression device in out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised trial and economic evaluation
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dolutegravir, Abacavir and Lamivudine (Triumeq®) in HIV infection]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sofosbuvir/velpatasvir/voxilaprevir (chronic hepatitis C) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Pre-conception care for women with type 1 or type 2 diabetes: a mixed methods study exploring uptake of pre-conception care
2017     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) [Trancatheter ablation with cryoballoon for the treatment of atrial fibrillation. A rapid assessment]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Rituximab biosimilars]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Carfilzomib (multiple myeloma) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nintedanib (Ofev®) in the treatment of idiopathic pulmonary fibrosis]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sarilumab (rheumatoid arthritis) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Matrix-assisted laser desorption/ionization-time of flight analyzer (MALDI-TOF) in infections]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Daratumumab (multiple myeloma) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Home-based health promotion for older people with mild frailty: the HomeHealth intervention development and feasibility RCT
2017     NIHR Health Technology Assessment programme Modifying Alcohol Consumption to Reduce Obesity (MACRO): development and feasibility trial of a complex community-based intervention for men
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Single-donor platelet concentrate in patients with thrombocytopenia]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ledipasvir/sofosbuvir (hepatitis C) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Public Health Research (PHR) programme Steps Towards Alcohol Misuse Prevention Programme (STAMPP): a school- and community-based cluster randomised controlled trial
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Peritoneal dialysis versus hemodialysis for end stage renal disease]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Update of the guideline synopsis for the DMP "rheumatoid arthritis" - rapid report]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dimethyl fumarate in multiple sclerosis: Comparison among different commercially available trademarks in Argentina]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brodalumab (plaque psoriasis) - Benefit assessment according to §35a Social Code Book V]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Cerebrospinal fluid neurotransmitter screening in encephalopathies]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elosulfase alfa (mucopolysaccharidosis type IVA) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V (new scientific findings)]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Vemurafenib in combination with Cobimetinib for advanced melanoma]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ribociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V]
2017     Health Sciences Institute in Aragon (IACS) Motorised assistive walking device in patients with muscle weakness in the lower limbs
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Pelvic vein embolization or sclerotherapy in pelvic congestion syndrome]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (urothelial carcinoma) - Benefit assessment according to §35a Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Analysis of clinical studies of medical devices]
2017     NIHR Health Technology Assessment programme A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyperbaric oxygen therapy for chronic ulcers]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Avelumab (metastatic Merkel cell carcinoma) - Benefit assessment according to §35a (1), Sentence 11, Social Code Book V]
2017     NIHR Health Technology Assessment programme The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intravesical hyaluronic acid in interstitial cystitis/painful bladder syndrome]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Uncertainty in the efficiency frontiers]
2017     NIHR Health Technology Assessment programme Observational study to estimate the changes in the effectiveness of bacillus Calmette Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK
2017     NIHR Health Technology Assessment programme Managing Faecal INcontinence in people with advanced dementia resident in Care Homes (FINCH) study: a realist synthesis of the evidence
2017     NIHR Health Technology Assessment programme Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Trabecular bone score-TBS for bone fragility diagnosis]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Darunavir-cobicistat-emtricitabine-tenofovir alafenamide (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Antibodies to pgp9.5 in small fiber neuropathy]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dimethyl fumarate (psoriasis) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Assessing the performance of methodological search filters to improve the efficiency of evidence information retrieval: five literature reviews and a qualitative study
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Ketoanalogue diet for advanced chronic kidney failure]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma, first-line treatment) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial
2017     NIHR Health Technology Assessment programme Facet-joint injections for non-specific low back pain: a feasibility RCT
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Biologics in patients with spondyloarthritis]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial)
2017     NIHR Health Technology Assessment programme Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical Practice Guideline about breastfeeding]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Stereotactic body radiation therapy in pancreatic cancer]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V]
2017     Canary Health Service [Tools for early detection of disease-related malnutrition for adult population in the hospital setting]
2017     NIHR Health Technology Assessment programme Virtual chromoendoscopy for the real-time assessment of colorectal polyps in vivo: a systematic review and economic evaluation
2017     Basque Office for Health Technology Assessment (OSTEBA) [Guide for breastfeeding mother. Guide for women who wish to breastfeed or who breastfeed, as well as their partners and family]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Complete exome sequencing in epileptic encephalopathy]
2017     Canary Health Service [Safety, clinical effectiveness and cost-effectiveness of platelet-rich plasma for the treatment of chronic wounds]
2017     NIHR Health Technology Assessment programme Surveillance versus ablation for incidentally diagnosed small renal tumours: the SURAB feasibility RCT
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guidelines on lipid management as a cardiovascular risk factor]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Endoscopic surgery in patients with middle ear conditions]
2017     HAYES, Inc. Acclarent eustachian tube balloon dilation for the treatment of eustachian tube dysfunction inadults
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dinutuximab for patients with high-risk neuroblastoma]
2017     Canary Health Service [Cost-effectiveness of pneumococcal vaccination in adults older than 60 years]
2017     HAYES, Inc. Bielfeld eustachian tube balloon dilation for the treatment of chronic eustachian tube dysfunction in adults
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Tearlab® osmolarity system for dry eye]
2017     Canary Health Service [Argus II. Retinal Prosthesis System]
2017     HAYES, Inc. Buprenorphine extended-release implant (Probuphine; Braeburn Pharmaceuticals Inc.) for opioid use disorder
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Preimplantational genetic diagnosis (pgt-a) in assisted reproduction technologies]
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for hepatitis C virus: a systematic review
2017     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Home use of a mechanical cough-assist insufflation-exsufflation device for adults with neuromuscular diseases who do not require ventilatory support]
2017     Canary Health Service [High definition direct current transcranial stimulation (HD-tDCS) in Fibromyalgia]
2017     NIHR Health Technology Assessment programme Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study
2017     HAYES, Inc. Impella CP (Abiomed) for use in adult patients with cardiogenic shock
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [HD Analyzer® in cataract and dry eye]
2017     Canary Health Service [Effectiveness, safety and cost-effectiveness of the flash interstitial fluid glucose monitoring system (FreeStyle Libre®) for diabetes mellitus type 1 and 2 (Update Appendix)]
2017     HAYES, Inc. Noncontact low-frequency ultrasound using the MIST Therapy System (Celleration Inc.) for treatment of venous leg ulcers
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Infrared meibography for meibomian gland disease]
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for the treatment of obstructive sleep apnea in adults: a health technology assessment
2017     HAYES, Inc. Peripheral nerve ablation for treatment of osteoarthritic knee pain
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Prosthesis replacement in ankle osteoarthritis]